A cautious hope for cannabidiol (CBD) in rheumatology care.

Cannabidiol (CBD), a major metabolite of Cannabis sativa, is popularized as a medicinal product, with potential for analgesic, anti-inflammatory and antioxidant effects. CBD may hold promise as a treatment in rheumatic diseases, but evidence to date remains preclinical. Preclinical effects on pain and inflammation is encouraging, but clinical study is lacking with only a single study in knee osteoarthritis reporting promising effect on symptoms.

The post A cautious hope for cannabidiol (CBD) in rheumatology care. appeared first on Weed World Magazine.